-
公开(公告)号:JPS5942364A
公开(公告)日:1984-03-08
申请号:JP15281082
申请日:1982-09-03
申请人: Teijin Ltd
发明人: SUGIURA SATOSHI , SAKAUCHI KIYOSHI , YUU TAKESHI , KUROZUMI SEIJI
IPC分类号: C07C405/00 , C07C67/00 , C07C401/00
摘要: PURPOSE: To obtain the titled compound useful as a labor pain promotor or intestinal hyperkinetic agent, etc. from an easily available raw material in high yield in short step, by reducing a 7-sulfonyloxyprostaglandin F.
CONSTITUTION: A 7-sulfonyloxyprostaglandin F of formula I (B is -CH
2 -CH
2 , -CH=CH- or -C≡C-,; R
1 is H, 1W10C alkyl, phenyl or cycloalkyl, etc.; R
2 is 1W14C alkyl, phenyl, etc.; R
3 and R
4 are H, OH, etc.; R
5 is unsubstituted 1W 8C alkyl, phenyl, etc.; R
6 is H, methyl, ethynyl, etc.; the dotted line part is a single or double bond) is reduced with a reducing reaction agent, e.g. sodium boron hydride, in a solvent, e.g. hexamethylphosphoric triamide or dimethyl sulfoxide, at 0W150°C, preferably 30W100°C, to give the aimed substance of formula II.
COPYRIGHT: (C)1984,JPO&Japio摘要翻译: 目的:通过减少7-磺酰氧基前列腺素F,从短容易地获得的原料中获得用作劳动疼痛促进剂或肠肌运动剂等的标题化合物。构成:式7的7-磺酰氧基前列腺素F I(B是-CH 2 -CH 2,-CH = CH-或-C≡C),R 1是H,1-10C烷基,苯基或环烷基等; R 2是1-14C烷基,苯基 等; R 3和R 4是H,OH等; R 5是未取代的1- 8C烷基,苯基等; R 6是H,甲基,乙炔基等。 ;虚线部分是单键或双键)用还原反应剂还原,例如 硼氢化钠。 六甲基磷酰三胺或二甲基亚砜,在0-150℃,优选30-100℃,得到式II的目标物质。
-
公开(公告)号:JPS5867682A
公开(公告)日:1983-04-22
申请号:JP16420081
申请日:1981-10-16
申请人: TEIJIN LTD
发明人: SAKAUCHI KIYOSHI , YUU TAKESHI , OOBA TAKEO , TANAKA TOSHIO , OKAMURA NORIAKI , WATANABE KENZOU , KUROZUMI SEIJI , OOTSU AKIRA , NARITOMO TATSUYUKI
IPC分类号: C07D307/935 , C07F7/18
摘要: PURPOSE:To prepare the titled compound having high stability and useful as a remedy for thrombosis, a hypotensor, etc., from an easily available raw material, by reacting a specific 5-halo-DELTA -PGI1 with a fluorination reagent such as a metal fluoride, etc. CONSTITUTION:The objective compound of formula II (R is H or 1-10C alkyl; R and R are H or OH-protecting group; R is fluorine atom and R and R together form a single bond, or R is fluorine atom and R and R together form a single bond) can be prepared by reacting the 5-halo-DELTA -PGI1 of formulaI(R is H or 1-10C alkyl; R and R are H or OH-protecting group; X is Cl, Br or I) (e.g. 5-bromo-DELTA -PGI1 methyl ester 11,15-diacetate) with a fluorinating reagent such as a metal fluoride (e.g. silver fluoride) in a solvent such as acetonitrile.
-
公开(公告)号:JPS5818366A
公开(公告)日:1983-02-02
申请号:JP11533781
申请日:1981-07-24
申请人: TEIJIN LTD
发明人: TANAKA TOSHIO , YUU TAKESHI , OKAMURA NORIAKI , SAKAUCHI KIYOSHI , HANESATO ATSUO , MANABE KENJI , OOBA TAKEO , WATANABE KENZOU , KUROZUMI SEIJI , OOTSU AKIRA , KAMIMOTO FUKUYOSHI
IPC分类号: C07D233/60 , A61K31/415 , A61K31/47 , A61P7/02 , A61P9/08 , A61P9/10 , A61P29/00 , C07D401/12
摘要: NEW MATERIAL:A 1-aryloxyethylimidazole derivative expressed by formulaI(A is methine or N) and an acid addition salt thereof. EXAMPLE:1-[2-(2-Naphthyloxy)ethyl]imidazole. USE:An inhibitor of blood platelet agglutination, preventing agent for apoplexy, antiagglutinating agent of blood platelets, remedy for pulmonary embolism, endotoxic shock, asthma and cardiac infarction, vasodilator of coronary artery, antiarteriosclerotic agent, antiulcer agent, remedy for nephritis, etc. PROCESS:An aryloxyethyl halide expressed by formula II (X is Cl, Br or I) is reacted with imidazole in a solvent, e.g. N,N-dimethylformamide, in the presence of a base, e.g. NaH, at -20-+50 deg.C for 5min-24hr to give the compound expressed by formulaI.
-
公开(公告)号:JPS57165363A
公开(公告)日:1982-10-12
申请号:JP5049181
申请日:1981-04-06
申请人: TEIJIN LTD
发明人: KUROZUMI SEIJI , YUU TAKESHI , OOBA TAKEO , TANAKA TOSHIO , OKAMURA NORIAKI , WATANABE KENZOU , SAKAUCHI KIYOSHI , HASATO ATSUO , OOTSU AKIRA , KAMIMOTO FUKUYOSHI
IPC分类号: C07C405/00 , A61K31/557 , A61K31/5575 , A61P43/00 , C07C67/00 , C07C401/00 , C07F7/18
摘要: NEW MATERIAL:The compound of formulaI(R is H or 1-10C alkyl; R is 1-10C alkyl or cycloalkyl; R is H or methyl; R and R are H or protecting group) and its non-toxic salt. EXAMPLE:4-Thiaprostaglandin E10. USE:Blood platelet coagulation suppressing agent and vasodilating agent. It is useful, e.g. for the remedy and prevention of thrombosis or as a hypotensor, etc. PROCESS:The compound of formulaIis prepared by reacting an alpha-allyl ketone compound of formula II (R and R are protecting group) with a thiol compound of formula III at -30-+200 deg.C for 10min-30hr, and if necessary, eliminating the protecting group and/or hydrolyzing the product.
-
公开(公告)号:JPS56150041A
公开(公告)日:1981-11-20
申请号:JP5224180
申请日:1980-04-22
申请人: TEIJIN LTD
发明人: YUU TAKESHI , TANAKA TOSHIO , OOBA TAKEO , OKAMURA NORIAKI , SAKAUCHI KIYOSHI , WATANABE KENZOU , KUROZUMI SEIJI , OKAMIYA YOSHIAKI , NARITOMO TATSUYUKI
IPC分类号: C07C69/738 , A61K31/23 , A61K31/557 , A61K31/695 , A61P43/00 , C07C51/373 , C07C59/90 , C07C67/313 , C07F7/18
摘要: NEW MATERIAL:A seco-prostaglandin derivative of formula I (R is H or 1-6C alkyl; R is CH3 or C2H5; Z is H or protecting group). EXAMPLE:6-Oxo-8-acetyl-12(S)-hydroxyheptadeca-10-trans-enoic acid methyl ester. USE:Drug. It can be applied to the vascular vessel, kidney, digestive tracts, etc., and is effective to control inflammation, blood coagulation, blood platelet, and immune function. It can be synthesized easily, and obtained at a low cost. The activity similar to prostaglandin can be expected. PROCESS:The compound of formula III obtained by the hydrolysis of the compound of formula II (R ' is 1-6C alkyl; Z' is protecting group) in the presence of an acidic catalyst (e.g. acetic acid, formic acid, etc.), is oxidized with chromic acid, etc., and if necessary, subjected to the elimination of the protecting group and hydrolysis to obtain the compound of formula I.
-
公开(公告)号:JPS5663979A
公开(公告)日:1981-05-30
申请号:JP13938579
申请日:1979-10-30
申请人: TEIJIN LTD
发明人: TANAKA TOSHIO , YUU TAKESHI , OOBA TAKEO , OKAMURA NORIAKI , WATANABE KENZOU , SAKAUCHI KIYOSHI , KUROZUMI SEIJI
IPC分类号: C07D307/935 , A61K31/34 , A61K31/343 , A61P43/00
摘要: NEW MATERIAL:A compound of formula I (R 1 and R2 are H or protecting group; Y is H; X is halogen, or X and Y together form a C-C bond). EXAMPLE:1,2,3,4-Tetranor-prostaglandin I2. USE:An intermediate for the production of a prostaglandin I2 analogue having blood platelet coagulation inhibiting, coagulated platelet dissolving, arterial duct relaxing, and hypotensive activities, etc. PROCESS:A compound of formula I wherein Y is H and X is halogen is prepared by the halogenative cyclization of a compound of formula II with a reaction reagent such as N-bromosuccinimide, etc. The compound thus prepared is converted to another compound of formula I wherein X and Y together form a C-C bond by reacting with an organic base, e.g. 1,5-diazabicyclo[5,4,0]undecene-5, in an organic solvent such as benzene at 0-150 deg.C, and subjecting the product to dehydrohalogenation reaction.
-
公开(公告)号:JPS5651452A
公开(公告)日:1981-05-09
申请号:JP12672579
申请日:1979-10-03
申请人: TEIJIN LTD
发明人: OOBA TAKEO , TANAKA TOSHIO , OKAMURA NORIAKI , WATANABE KENZOU , SAKAUCHI KIYOSHI , OOTSU AKIRA , NARITOMO TATSUYUKI , KUROZUMI SEIJI , YUU TAKESHI
IPC分类号: C07D209/12 , A61K31/40 , A61K31/403 , A61K31/404 , A61K31/60 , A61P7/02 , A61P9/08 , A61P9/10 , A61P29/00
摘要: NEW MATERIAL:Derivatives of acylated indole of formula I [R1 is lower alkyl or (substituted) phenyl; R2 is H or lower alkyl; R3 and R4 are H, halogen, lower alkoxy, lower alkylthio, lower alkylsulfinyl, amino, lower alkyl-substituted amino, trifluoromethyl, etc., or R3 and R4 together form methylenedioxy or ethylenedioxy; phi is aryl or alicyclic group]. EXAMPLE:3-Benzoyl-2-methyl-1-(3-oxo-2-butyl) indole. USE:Preventive agent for cardiac vascular infarction, preventive and treatment agent for post-operative diseases, antiinflamatory agent, fibrinolytic agent etc. It has excellent activity to suppress the coagulation of blood platelets. PROCESS:A compound of formula I is obtained by the reaction of e.g. a compound of formula II with a compound of formula III (X is halogen) in the presence of a basic compound.
-
公开(公告)号:JPS54117195A
公开(公告)日:1979-09-11
申请号:JP2338978
申请日:1978-03-01
申请人: TEIJIN LTD
-
公开(公告)号:JPS5368753A
公开(公告)日:1978-06-19
申请号:JP14329476
申请日:1976-12-01
申请人: TEIJIN LTD
IPC分类号: A61K31/215 , A61K31/19 , A61P43/00 , C07C67/00 , C07C313/00 , C07C323/52 , C07C401/00 , C07C405/00
摘要: PURPOSE:Titale compounds of formula I(A is C1-10 hydrocarbon radical, especially pentamethylene; B is C1-10 hydrocarbon redical, especially -CH2CH2-, CH=CH-; R ,R ,R are H, C1-10 hydrocarbon radial; R , R are H, OH), e.g. 7-thia-11-deoxyprostaglandin E1 methyl ester.
-
公开(公告)号:JPS5363357A
公开(公告)日:1978-06-06
申请号:JP13694076
申请日:1976-11-16
申请人: TEIJIN LTD
IPC分类号: C07D309/12 , C07C45/00 , C07C45/64 , C07C49/493 , C07C49/743 , C07C67/00 , C07F7/18
摘要: PURPOSE:The title cpds. I(R is 1-15C hydrocarbon residue which may have a hydroxy gp.),e.g. 3-[3(S)-t-butyldimethylsiloxy-oct-enyl]-2-hydroxymethylcyclopentanone.
-
-
-
-
-
-
-
-
-